Epinephrine-mediated changes in carbon dioxide tension during reperfusion of ventricular fibrillation in a canine model

M. G. Angelos, D. J. DeBehnke

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Previous studies suggest that epinephrine may alter the correlation of perfusion with measures of PCO2 during cardiopulmonary resuscitation. This study investigated the effects of epinephrine on PaCO2 and mixed venous PCO2 in a high-flow reperfusion model of cardiac arrest. Design: Prospective, block randomized, blinded, placebo-controlled, laboratory study. Subjects: Thirty mixed breed canines. Interventions: After a 12-min ventricular fibrillation cardiac arrest, 30 mixed breed canines were reperfused with standardized (3200 revolutions/min) cardiopulmonary bypass and were given placebo (n = 10), standard dose epinephrine (0.02 mg/kg; n = 10), or high-dose epinephrine (0.2 mg/kg; n = 10). Arterial and mixed venous blood gases, coronary perfusion pressure, pump flow and peripheral vascular resistance were compared between groups during the early reperfusion period using analysis of variance with a post hoc Tukey's multiple comparison test. Measurements and Main Results: Baseline variables were similar between groups. With reperfusion, the high-dose epinephrine group had higher coronary perfusion pressures (p < .002), lower systemic pump flow (p < .01), and higher peripheral vascular resistance (p < .001). In the high-dose epinephrine group, both PaCO2 (high-dose epinephrine, 40 ± 6 torr [5.3 ± 0.8 kPa]; standard dose epinephrine, 45 ± 7 torr [6.0 ± 0.9 kPa]; placebo, 54 ± 4 torr [7.2 ± 0.5 kPa];p < .01) and mixed venous PCO2 (high-dose epinephrine, 55 ± 10 torr [7.3 ± 1.3 kPa]; standard dose epinephrine, 57 ± 9 torr [7.6 ± 1.2 kPa]; placebo, 67 ± 4 torr [8.9 ± 0.5 kPa];p < .05) were significantly decreased, and arterial pH, PaO2, and mixed venous PO2 were significantly increased compared with the placebo group. Conclusion: In this model, when ventilation and CO2 production are constant, the decrease in PaCO2 with epinephrine is due to decreased pulmonary blood flow (flow to membrane oxygenator) and peripheral shunting.

Original languageEnglish (US)
Pages (from-to)925-930
Number of pages6
JournalCritical care medicine
Volume23
Issue number5
DOIs
StatePublished - Jan 1 1995

Fingerprint

Ventricular Fibrillation
Carbon Dioxide
Epinephrine
Reperfusion
Canidae
Vascular Resistance
Placebos
Heart Arrest
Perfusion
Membrane Oxygenators
Pressure
Infusion Pumps
Cardiopulmonary Resuscitation
Cardiopulmonary Bypass
Ventilation
Analysis of Variance
Gases
Demography
Lung

Keywords

  • blood gases
  • cardiopulmonary arrest
  • cardiopulmonary bypass
  • catecholamines
  • critical illness
  • end-tidal CO
  • epinephrine
  • pH
  • ventricular fibrillation

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Epinephrine-mediated changes in carbon dioxide tension during reperfusion of ventricular fibrillation in a canine model. / Angelos, M. G.; DeBehnke, D. J.

In: Critical care medicine, Vol. 23, No. 5, 01.01.1995, p. 925-930.

Research output: Contribution to journalArticle

@article{c20eb733448c4ab59200672f882ca2d4,
title = "Epinephrine-mediated changes in carbon dioxide tension during reperfusion of ventricular fibrillation in a canine model",
abstract = "Objective: Previous studies suggest that epinephrine may alter the correlation of perfusion with measures of PCO2 during cardiopulmonary resuscitation. This study investigated the effects of epinephrine on PaCO2 and mixed venous PCO2 in a high-flow reperfusion model of cardiac arrest. Design: Prospective, block randomized, blinded, placebo-controlled, laboratory study. Subjects: Thirty mixed breed canines. Interventions: After a 12-min ventricular fibrillation cardiac arrest, 30 mixed breed canines were reperfused with standardized (3200 revolutions/min) cardiopulmonary bypass and were given placebo (n = 10), standard dose epinephrine (0.02 mg/kg; n = 10), or high-dose epinephrine (0.2 mg/kg; n = 10). Arterial and mixed venous blood gases, coronary perfusion pressure, pump flow and peripheral vascular resistance were compared between groups during the early reperfusion period using analysis of variance with a post hoc Tukey's multiple comparison test. Measurements and Main Results: Baseline variables were similar between groups. With reperfusion, the high-dose epinephrine group had higher coronary perfusion pressures (p < .002), lower systemic pump flow (p < .01), and higher peripheral vascular resistance (p < .001). In the high-dose epinephrine group, both PaCO2 (high-dose epinephrine, 40 ± 6 torr [5.3 ± 0.8 kPa]; standard dose epinephrine, 45 ± 7 torr [6.0 ± 0.9 kPa]; placebo, 54 ± 4 torr [7.2 ± 0.5 kPa];p < .01) and mixed venous PCO2 (high-dose epinephrine, 55 ± 10 torr [7.3 ± 1.3 kPa]; standard dose epinephrine, 57 ± 9 torr [7.6 ± 1.2 kPa]; placebo, 67 ± 4 torr [8.9 ± 0.5 kPa];p < .05) were significantly decreased, and arterial pH, PaO2, and mixed venous PO2 were significantly increased compared with the placebo group. Conclusion: In this model, when ventilation and CO2 production are constant, the decrease in PaCO2 with epinephrine is due to decreased pulmonary blood flow (flow to membrane oxygenator) and peripheral shunting.",
keywords = "blood gases, cardiopulmonary arrest, cardiopulmonary bypass, catecholamines, critical illness, end-tidal CO, epinephrine, pH, ventricular fibrillation",
author = "Angelos, {M. G.} and DeBehnke, {D. J.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1097/00003246-199505000-00022",
language = "English (US)",
volume = "23",
pages = "925--930",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Epinephrine-mediated changes in carbon dioxide tension during reperfusion of ventricular fibrillation in a canine model

AU - Angelos, M. G.

AU - DeBehnke, D. J.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Objective: Previous studies suggest that epinephrine may alter the correlation of perfusion with measures of PCO2 during cardiopulmonary resuscitation. This study investigated the effects of epinephrine on PaCO2 and mixed venous PCO2 in a high-flow reperfusion model of cardiac arrest. Design: Prospective, block randomized, blinded, placebo-controlled, laboratory study. Subjects: Thirty mixed breed canines. Interventions: After a 12-min ventricular fibrillation cardiac arrest, 30 mixed breed canines were reperfused with standardized (3200 revolutions/min) cardiopulmonary bypass and were given placebo (n = 10), standard dose epinephrine (0.02 mg/kg; n = 10), or high-dose epinephrine (0.2 mg/kg; n = 10). Arterial and mixed venous blood gases, coronary perfusion pressure, pump flow and peripheral vascular resistance were compared between groups during the early reperfusion period using analysis of variance with a post hoc Tukey's multiple comparison test. Measurements and Main Results: Baseline variables were similar between groups. With reperfusion, the high-dose epinephrine group had higher coronary perfusion pressures (p < .002), lower systemic pump flow (p < .01), and higher peripheral vascular resistance (p < .001). In the high-dose epinephrine group, both PaCO2 (high-dose epinephrine, 40 ± 6 torr [5.3 ± 0.8 kPa]; standard dose epinephrine, 45 ± 7 torr [6.0 ± 0.9 kPa]; placebo, 54 ± 4 torr [7.2 ± 0.5 kPa];p < .01) and mixed venous PCO2 (high-dose epinephrine, 55 ± 10 torr [7.3 ± 1.3 kPa]; standard dose epinephrine, 57 ± 9 torr [7.6 ± 1.2 kPa]; placebo, 67 ± 4 torr [8.9 ± 0.5 kPa];p < .05) were significantly decreased, and arterial pH, PaO2, and mixed venous PO2 were significantly increased compared with the placebo group. Conclusion: In this model, when ventilation and CO2 production are constant, the decrease in PaCO2 with epinephrine is due to decreased pulmonary blood flow (flow to membrane oxygenator) and peripheral shunting.

AB - Objective: Previous studies suggest that epinephrine may alter the correlation of perfusion with measures of PCO2 during cardiopulmonary resuscitation. This study investigated the effects of epinephrine on PaCO2 and mixed venous PCO2 in a high-flow reperfusion model of cardiac arrest. Design: Prospective, block randomized, blinded, placebo-controlled, laboratory study. Subjects: Thirty mixed breed canines. Interventions: After a 12-min ventricular fibrillation cardiac arrest, 30 mixed breed canines were reperfused with standardized (3200 revolutions/min) cardiopulmonary bypass and were given placebo (n = 10), standard dose epinephrine (0.02 mg/kg; n = 10), or high-dose epinephrine (0.2 mg/kg; n = 10). Arterial and mixed venous blood gases, coronary perfusion pressure, pump flow and peripheral vascular resistance were compared between groups during the early reperfusion period using analysis of variance with a post hoc Tukey's multiple comparison test. Measurements and Main Results: Baseline variables were similar between groups. With reperfusion, the high-dose epinephrine group had higher coronary perfusion pressures (p < .002), lower systemic pump flow (p < .01), and higher peripheral vascular resistance (p < .001). In the high-dose epinephrine group, both PaCO2 (high-dose epinephrine, 40 ± 6 torr [5.3 ± 0.8 kPa]; standard dose epinephrine, 45 ± 7 torr [6.0 ± 0.9 kPa]; placebo, 54 ± 4 torr [7.2 ± 0.5 kPa];p < .01) and mixed venous PCO2 (high-dose epinephrine, 55 ± 10 torr [7.3 ± 1.3 kPa]; standard dose epinephrine, 57 ± 9 torr [7.6 ± 1.2 kPa]; placebo, 67 ± 4 torr [8.9 ± 0.5 kPa];p < .05) were significantly decreased, and arterial pH, PaO2, and mixed venous PO2 were significantly increased compared with the placebo group. Conclusion: In this model, when ventilation and CO2 production are constant, the decrease in PaCO2 with epinephrine is due to decreased pulmonary blood flow (flow to membrane oxygenator) and peripheral shunting.

KW - blood gases

KW - cardiopulmonary arrest

KW - cardiopulmonary bypass

KW - catecholamines

KW - critical illness

KW - end-tidal CO

KW - epinephrine

KW - pH

KW - ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=0029031412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029031412&partnerID=8YFLogxK

U2 - 10.1097/00003246-199505000-00022

DO - 10.1097/00003246-199505000-00022

M3 - Article

C2 - 7736752

AN - SCOPUS:0029031412

VL - 23

SP - 925

EP - 930

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 5

ER -